Introduction:
Chronic Renal Insufficiency is a major public health problem. The number of patients with End Stage Renal Disease has steadily increased over the years. In the United States, the rate has been reported as 6-7% per year 3 In India, the incidence of Chronic Kidney Disease was suggested to be 100 per million populations by single centre studies from tertiary care hospital. Upto 0.8% of the population may suffer from Chronic Kidney Disease thereby putting the number at about 7.85 million of the 1billion population 4 .
Effect of chronic kidney disease on cardiovascular system
Cardiovascular Disease is the leading cause of morbidity and mortality in patients at every stage of Chronic Kidney Disease. There is a 10-200 fold increased risk of cardiovascular disease in those with Chronic Kidney Disease compared to the age and sex matched with general population, depending on the stage of Chronic Kidney Disease. Between 30-45% patients of Chronic Kidney Disease reaching stage 5 Chronic Kidney Disease already have advanced cardiovascular complications, so many patients succumb to cardiovascular disease before ever reaching stage 5 Chronic Kidney Disease 12 .
Ischemic vascular changes
The presence of any stage of Chronic Kidney Disease is a major risk factor for ischemic cardiovascular disease, including occlusive coronary, cerebrovascular and peripheral vascular disease. The increased prevalence is due to traditional (classic) i.e. Hypertension, Hypervolemia, Dyslipidemia, Sympathetic overactivity and hyperhomocysteinemia and non traditional (CKD related) risk factors like Anemia, Hyperphosphatemia, Hyperparathyroidism, Sleep Apnoea, and generalised inflammation. Coronary reserve, defined as increase in coronary blood flow in response to greater demand is also attenuated. Cardiac Troponin levels are also elevated in Chronic Kidney Disease without evidence of acute ischemia, thus complicating the diagnosis of myocardial infarction in these patients 7 .
Peripheral vascular disease
The inflammatory state associated with reduction in kidney function is reflected in increased circulating acute phase reactants, such as inflammatory cytokines and C-reactive protein, with corresponding fall in the negative acute phase reactants such as albumin and fetuin. The inflammatory state accelerates vascular occlusive diseases, and low level of fetuin permits more rapid vascular calcification, especially in the face of hyperphosphatemia. Heart failure In Chronic Kidney Disease, abnormal cardiac function secondary to myocardial ischemia, left ventricular hypertrophy, and frank cardiomyopathy, along with salt and water retention often results in heart failure or even episodes of pulmonary edema. A form of low pressure pulmonary edema can also occur in advanced Chronic Kidney Disease, manifesting as shortness of breath and bat wing distribution of alveolar edema fluid on the chest x-ray. This occurs due to increased permeability of alveolar capillary membranes due to uremic state. Other Chronic Kidney Disease-related risk factors, including anaemia and sleep apnoea, may also contribute to risk of heart failure 6 . Hypertension and left ventricular hypertrophy LVH is highly prevalent in both stages 3 and 4 CKD and dialysis patients and represents a physiologic adaptation to a long term increase in myocardial work requirements 8 . Cardiomyopathy are among the strongest risk factors for cardiovascular morbidity and mortality in patients with Chronic Kidney Disease and, are thought to be related primarily, but not exclusively, to prolonged hypertension and ECFV overload. Also anaemia due to Chronic Kidney Disease can also generate high cardiac output state and subsequent heart failure 11 .
Pericardial Disease
Chest pain with respiratory accentuation, accompanied by a friction rub, is diagnostic of pericarditis. Classic electrocardiographic abnormalities include PR-interval depression and diffuse ST-segment elevation. Pericarditis can be accompanied by pericardial effusion that is seen on echocardiography and can rarely lead to tamponade, however, the pericardial effusion can be asymptomatic, and pericarditis can be seen without significant effusion. Pericarditis is seen in advanced uraemia, and is more often observed in underdialyzed, nonadherent patients than those in those starting and those adherents to dialysis. Pericarditis is frequently seen in peritoneal dialysis patient than it occurs in haemodialysis patient 10 .
Arrhythmias
Arrhythmias are very frequently seen in elderly during dialysis because of metastatic complication, amyloidal infiltration, coronary heart disease, cardiac hypertrophy, and hypertension are more frequent than in younger patients. Uraemia, hyperkalemia, acidosis and disorders of calciumphosphate balance have been associated with higher rates of supraventricular and ventricular arrhythmias. Due to presence of conditions like left ventricular hypertrophy, left ventricular dilation, heart failure and valvular diseases, higher rates of almost all arrhythmias are seen in Chronic Kidney Disease, including bradyarrythmias and heart block 12 .
Objective:
The objective of the study was to see Correlation, if any, of cardiac status and stage of kidney disease.
Materials and methods:
The study was conducted at M. M. Institute of Medical Sciences and Research, Mullana, Ambala. Thirty patients of Chronic Kidney Disease were included in the study. The patients taken from Outpatient department (OPD) and Indoor wards of the department of Medicine and Emergency Department. Chronic Kidney Disease is defined as kidney damage lasting for more than 3 months characterised by structural or functional abnormalities of the kidney, with or without decreased Glomerular Filtration Rate (GFR), according to the K/DOQI Guidelines1.
Inclusion criteria
Inclusion criteria was based on symptomatology and clinical history of features suggestive of Chronic Kidney Disease. Symptoms, Signs and history of the patients were used to filter out patients who did not fit in the criteria and selected patients on the basis of criteria were further evaluated and investigated. All patients were subjected to detailed history and clinical examination All patients were subjected to following investigations at the beginning of the study, like - History: a detailed history regarding duration of illness, any treatment received and past history of illness was taken. Age and sex of the patient was noted. b.
General Physical Examination: a detailed general physical examination was done with special reference to pulse rate and character, blood pressure, jugular venous pressure, presence of pallor, clubbing or pedal edema. c.
Respiratory and Cardiovascular Examination: a thorough examination of chest and CVS was done with emphasis of features of emphysema and evidence of left ventricular overload i.e. shortness of breath, pulmonary edema, orthopnoea and paroxysmal nocturnal dyspnoea, soft first heart sound, apex beat displaced outwards, heave often present, high pitched pansystolic murmur at the apex, radiating to the back or clavicular area etc.
2.
Chest Roentgenogram Posteroanterior films were obtained in all subjects. The following parameters were noted: -Low, flat or irregular diaphragm -Air trapping or bullae -Increased transradiancy -Main pulmonary artery shadow enlargement -Prominent bronchovascular markings -Cardiomegaly/ narrow heart shadow -Increased distance between intercostal spaces -Pleural Effusion -unilateral/ bilateral.
Electrocardiography (ECG)
A standard 12 lead ECG was done in all cases. Abnormalities on the ECG often provide the first evidence of cardiac dysfunction in patients in whom it is suspected. Diagnosis of LVH on electrocardiogram was made using Romhilt-Estes point score system95. 17 . The mean S. Creatinine values were 10.33 ± 4.95 mg/dl in the among the study cases of CKD in the present study. In the present study, Hemoglobin levels were below 10 gm/dl in all the patients (except 1). More than one-third of the patients had Hemoglobin levels below 7gm/dl, thereby emphasising the need for correction of Anemia in patients of CKD. This was comparable with the study by Foley et al 17 having mean Hemoglobin levels of 8.4 ± 1.7 gm/dl in CKD patients and 5.45 ± 2.26 gm/ dl in a study by London GM 25 . In present study, mean S. Potassium levels in CKD patients 5.54 ± 0.54 mEq/ L. This was comparable to S. Potassium levels of ≥ 5 mEq/ L in studies conducted by Singh NP et al 25 and Hayes et al 20 . If LVHis detected on ECG it usually means that an advanced degree of cardiac involvement has already occurred. ECG is inexpensive, easy to perform and provides additional prognostic information. In this study the Romhilt-Estes Point score system 27 was used to find the prevalence of LVH in CKD patients. Subjects having a score of 5 or more points were considered to have LVH in Hypertensive subjects. In the present study all the cases had ECG changes, with LVH present unanimously in all the ECGs. In almost 1/4th of the patients (23%) it had changes associated with Hyperkalemia viz-Tall tented Twaves, prolonged QT interval. The ECG changes were in confirmity with those in study conducted by Stewart GA et al 9 , who observed > 80% had LVH, also prolonged QT interval was found associated with poor Renal function, these features were also comparable to another study by Makusidi et al 19 who observed ECG changes in patients of CKD with LVH, Left Atrial Enlargement and other changes in 86% patients in his study. Cardiomegaly and Pleural Effusion bilaterally was also observed in Chest X Rays of the study cases of CKD in the present study. Cardiomegaly was seen in majority of the cases (93.3%) and was frequently (33%) associated with bilateral Pleural Effusion on the study of C X-rays. This was comparable with the study carried by M Golshan et al 24 who found CKD as a cause of pleural effusion in 6 of 106 patients with transudative pleural effusion in his study involving 213 patients with pleural effusion. This observation was also backed by another study conducted by Ray S et al 23 whose study had CKD, uremic pleural effusion accounted for 19% of the total pleural effusion cases studied by them.
Echocardiography

Left ventricular echo parameters
In the present study, majority of the study cases showed LVH on echocardiography. This was comparable to the study conducted by Foley et al among the patients of Chronic Kidney Disease 15, 17 . LVH is defined as an increase in Left Ventricular Mass, which was detected by echo in patients of CKD . In the present study the mean Left Ventricular Mass was 249.76 ± 69.35 gms with 73% study cases having Left Ventricular Mass more than the reference range, also Left Ventricular Mass showed a progressive rise with increase in S.Creatinine levels. This was comparable to study conducted by Foley et al 15, 17 and Angela Wang et al 29 who on performing echocardiography in patients of CKD found high prevalence of LVH in them. The mean thickness of Inter Ventricular Septum in diastole (12.55 ± 1.33 mm) and systole (15.56 ± 2.20 mm) was significantly increased than the normal reference range in cases of CKD in present study, which was comparable with the study results by Agrawal et al 16 ( IVSd-13 ± 3.0 mm, IVSs-15±3.0mm) and Yildiz et al58 who in their study observed significantly higher Interventricular Septum thickness (IVSd-13 ± 3.6 mm). Left Ventricular Internal Diameter in systole in the study was 30.42 ± 6.04 mm and diastole in patients of CKD was 44.43 ± 7.26mm, both internal diameters were well within normal limits, this was comparable with those in study conducted by Agrawal S et al 16 (LVIDs-27 ± 0.7 mm, LVIDd-40 ± 0.7 mm), where the Left Ventricular Internal Diameter was also within the normal reference range. However increase in diameter was observed with increasing severity of CKD among cases. Shah et al 22 , in their study also had similar observations (LVIDs-37.46 ± 6.6 mm, LVIDd-50.34 ± 15.7 mm). In the present study, the Left Ventricular Posterior Wall thickness in diastole was 13.51 ± 6.42 mm and in systole was 16.69 ± 1.78 mm, which was higher than the normal reference range. This was in conformity with the thickness of posterior wall in diastole 12.75 ± 0.2 mm as studied by Agrawal et al 16 .
In this study, majority of the patients showed LVH as evident by increase in Left Ventricular Mass. Left Ventricular Mass was calculated by using Devereux Regression 25 . Left ventricular Mass was found to be significantly increased as was evident by increase in thickness of Interventricular Septum in diastole and Left Ventricular Posterior Wall thickness, with the increase in severity of the disease. This was comparable to observations in the study conducted by Meyeon P et al 30 , who documented an increase in Left Ventricular Mass with increase in severity of the disease in CKD patients. The present study results are also comparable to study by Farshid A et al 18 
